Table 3.
Coef. | d | 95% CI of Coef. | ||
---|---|---|---|---|
| ||||
Lower | Upper | |||
GAD | ||||
Timepoint (Pre vs. Post) | −4.82 *** | −1.54 | −6.19 | −3.44 |
Timepoint (Pre vs. 3mo) | −4.94 *** | −1.59 | −6.32 | −3.57 |
Timepoint (Pre vs. 6mo) | −4.43 *** | −0.40 | −5.81 | −3.06 |
Treatment × Timepoint (Pre vs. Post) | 0.61 | 0.04 | −1.34 | 2.57 |
Treatment × Timepoint (Pre vs. 3mo) | 0.01 | < 0.01 | −1.96 | 1.98 |
Treatment × Timepoint (Pre vs. 6mo) | −0.56 | −0.12 | −2.54 | 1.43 |
PROMIS Anxiety | ||||
Timepoint (Pre vs. Post) | −7.40 *** | −1.70 | −9.32 | −5.48 |
Timepoint (Pre vs. 3mo) | −7.59 *** | −1.75 | −9.51 | −5.67 |
Timepoint (Pre vs. 6mo) | −6.26 *** | −0.40 | −8.19 | −4.33 |
Treatment × Timepoint (Pre vs. Post) | 2.89* | 0.13 | 0.15 | 5.63 |
Treatment × Timepoint (Pre vs. 3mo) | 1.08 | 0.05 | −1.68 | 3.85 |
Treatment × Timepoint (Pre vs. 6mo) | 0.93 | 0.15 | −1.86 | 3.73 |
PROMIS Depression | ||||
Timepoint (Pre vs. Post) | −5.78 *** | −1.37 | −7.65 | −3.91 |
Timepoint (Pre vs. 3mo) | −5.64 *** | −1.33 | −7.51 | −3.77 |
Timepoint (Pre vs. 6mo) | −5.16*** | −0.34 | −7.04 | −3.28 |
Treatment × Timepoint (Pre vs. Post) | 2.97* | 0.14 | 0.30 | 5.64 |
Treatment × Timepoint (Pre vs. 3mo) | 2.72 * | 0.13 | 0.02 | 5.42 |
Treatment × Timepoint (Pre vs. 6mo) | 2.52 | 0.41 | −0.20 | 5.24 |
SDS | ||||
Timepoint (Pre vs. Post) | −6.93 *** | −1.66 | −8.77 | −5.08 |
Timepoint (Pre vs. 3mo) | −6.53 *** | −1.67 | −8.26 | −4.80 |
Timepoint (Pre vs. 6mo) | −6.51 *** | −0.47 | −8.25 | −4.77 |
Treatment × Timepoint (Pre vs. Post) | 2.53 | 0.12 | −0.17 | 5.23 |
Treatment × Timepoint (Pre vs. 3mo) | −0.16 | −0.01 | −2.66 | 2.35 |
Treatment × Timepoint (Pre vs. 6mo) | −0.01 | < 0.01 | −2.53 | 2.52 |
BADS | ||||
Timepoint (Pre vs. Post) | 11.71 *** | 1.94 | 9.05 | 14.36 |
Timepoint (Pre vs. 3mo) | 11.07 *** | 1.96 | 8.57 | 13.56 |
Timepoint (Pre vs. 6mo) | 8.80 *** | 0.44 | 6.29 | 11.30 |
Treatment × Timepoint (Pre vs. Post) | −4.68 * | −0.15 | −8.56 | −0.79 |
Treatment × Timepoint (Pre vs. 3mo) | −4.10 * | −0.14 | −7.70 | −0.49 |
Treatment × Timepoint (Pre vs. 6mo) | −1.10 | −0.13 | −4.74 | 2.53 |
Note. Models take the form symptom ~ timepoint × treatment-arm + age + sex + education, with participant ID and treatment group entered as random effects. BA: behavioral activation; EXP: exposure; GAD-7: Generalized Anxiety Disorder Scale - 7-item, PROMIS: Patient-Reported Outcomes Measurement Information System; SDS: Sheehan Disability Scale; BADS: Behavioral Activation for Depression Scale.
p < .001,
p < .01,
p < .05.